Unlike most of the body’s cells which regularly divide, die off, and renew themselves, neurons stay from birth until death. The process of keeping them healthy for a lifetime is extremely important, and the system responsible for this is called proteostasis, or protein homeostasis. Scientists attribute the natural aging process and disease pathology to gradual faults in this system . Understanding why it breaks down is one of the most pressing questions in neuroscience.

Proteins are the molecular building blocks that are only useful when correctly folded into precise three-dimensional shapes. Misfolded proteins are not just useless, but they can be actively toxic and aggregate to disrupt cellular machinery. To prevent this, cells maintain three defenses: molecular chaperones that assist protein folding, the ubiquitin proteasome system (UPS) that destroys damaged proteins tagged for disposal, and autophagy which engulfs large debris for breakdown. Together these form the proteostasis network (PN). Activity shifts across tissues and life stages, and this complexity has profound consequences for disease.

Not all cells face equal proteostatic pressure. Dividing cells dilute their burden of damaged proteins with each split, passing a fraction of cluttered damage to daughter cells. Neurons cannot do this since they are post-mitotic and must clear accumulated proteins through the PN with no reset. Some neurons extend axons over a meter in length, meaning proteins synthesized in the cell body must travel vast distances to synaptic terminals and back. These synaptic proteins are especially at risk, recycled far from the cell’s protein-making machinery and among the first casualties when the system falters.

All three stages of the PN decline with age: chaperone availability drops, proteasome activity slows, and autophagy becomes less efficient. The consequences appear in some devastating conditions such as amyloid-β and tau aggregates in Alzheimer’s disease, ɑ-synuclein Lewy bodies in Parkinson’s, and TDP-43 deposits in ALS. In a 2016 study, a team of Stanford researchers used engineered mouse models that allow cell-type specific tracking of neuronal proteins. The team found that neuronal protein half-life approximately doubled between young adult and aged mice. The same study catalogued an “aged neuronal aggregome” of 1,726 proteins found in aggregates in aging brains, half of which showed reduced degradation with age. Many were familiar disease-associated proteins; hundreds had never been linked to neurodegeneration before. Synaptic proteins were overrepresented throughout.

Proteostasis has long been viewed as each cell’s private responsibility, but emerging research is rewriting that assumption. Microglia — the brain's resident immune cells — actively engulf neuronal proteins, acting as a cellular waste-removal service. The Stanford study found that over half of the neuronal proteins accumulating in aged microglia already showed signs of proteostatic failure: slower degradation or aggregation. Meanwhile, a UCBerkeley study in C. elegans found that triggering a mitochondrial stress response in an astrocyte-like glia was sufficient to reduce protein aggregation in neurons, with protective signals relayed via small vesicles. Proteostasis in the nervous system, it turns out, is a collaborative enterprise.

Caloric restriction and exercise both upregulate autophagy with extended lifespan in model organisms by boosting the same pathway. HSP70-activating chaperone inducers and modulators of the integrated stress response are under active investigation. None have yet been proven to restore neuronal proteostasis in aging humans, but the field is advancing rapidly. A fuller understanding of how and when the network fails will be essential for developing therapies that keep the aging brain's protein quality control running for as long as possible, and maybe even one day reverse aging itself.

Keeping the neuronal desk clean is the molecular foundation of a healthy brain across a lifetime. When the system fails, the consequences range from subtle cognitive slowing to outright neurodegeneration or disease. What is now clear is that this failure is not a neuron-level problem alone, it involves the coordinated breakdown of multiple cell types over decades. Restoring proteostatic balance may be one of the most tractable paths to preserving brain health as we age.